Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor

Cell Motility and the Cytoskeleton

Volumn 46, Issue 1, 2000, Pages 28-42

  Witt Enderby, Paula A ^a   MacKenzie, Renee S ^a   McKeon, Raelene M ^a   Carroll, Elizabeth A ^b   Bordt, Shannon L ^a   Melan, Melissa A ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b HIRAM COLLEGE   (United States)

Author keywords

cAMP; Cytoskeletal organization; G proteins; Neurite outgrowth; Protein kinase A; Signal transduction

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MELATONIN; MELATONIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL TRANSFORMATION; CHO CELL; CONTROLLED STUDY; CYTOSKELETON; ENZYME INHIBITION; INSOMNIA; MICROTUBULE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELL SIZE; CENTROSOME; CHO CELLS; CRICETINAE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MELATONIN; MICROFILAMENTS; MICROTUBULES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NEURONS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUBULIN;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034120913     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0169(200005)46:1<28::AID-CM4>3.0.CO;2-5     Document Type: Article

References (70)

1. Albertini DF, Anderson E. 1974. The appearance and structure of intercellular connections during the ontogeny of the rabbit ovarian follicle with particular reference to gap junctions. J Cell Biol 63:234-250.
2. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1994. Molecular biology of the cell. 3rd ed. New York: Garland Press. 1293 p.
3. Barlow S. Gonzalez-Garay ML, West RR, Olmsted JB, Cabral F. 1994. Stable expression of heterologous microtubule-associated proteins (MAPs) in Chinese hamster ovary cells: evidence for differing roles of MAPs in microtubule organization. J Cell Biol 126:1017-1029.
4. Benitez-King G, Anton-Tay F. 1993. Calmodulin mediates melatonin cytoskeletal effects. Experientia 49:635-641.
5. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F. 1990. Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma NIE-115 cells. J Pineal Res 9:209-220.
6. 2+/calmodulin-dependent kinase II activity by melatonin. Biochim Biophys Acta 1290:191-196.
7. Boudewijn M, Burgering T, Bos J. 1995. Regulation of Ras-mediated signaling: more than one way to skin a cat. Trends Biochem Sci 20:18-23.
8. q/11 proteins. Mol Endocrinol 13:2025-2038.
9. Brzezinski A. 1997. Melatonin in humans. N Engl J Med 336:186-195.
10. Cardinali DP, Freire F. 1975. Melatonin effects on brain: interaction with microtubule protein, inhibition of fast axoplasmic flow and induction of crystalloid and tubular formations in the hypothalamus. Mol Cell Endocrinol 2:317-320.
11. Cassone VM, Warren WS, Brooks DS, Lu H. 1993. Melatonin, the pineal gland and circadian rhythms. J Biol Rhythms 8:573-581.
12. Cos S, Verduga R, Fernandez-Viadero C, Megias M, Crespo D. 1996. Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci Lett 216:113-116.
13. Creedon DJ, Johnson EM, Lawrence JC. 1996. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 271:20713-20718.
14. Drubin D, Feinstein SC, Shooter EM, Kirschner MW. 1985. Nerve growth factor-induced neurite outgrowth in PC 12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J Cell Biol 101:1799-1807.
15. Drubin D, Kobayashi S, Kellogg D, Kirschner M. 1988. Regulation of microtubule protein levels during cellular morphogenesis in nerve-growth factor-treated PC12 cells. J Cell Biol 106:1583-1591.
16. Dubocovich ML. 1995. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16:50-56.
17. Dubocovich ML, Masana MI, Iacoh S, Sauri DM. 1997. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heleroreceptor. Naunyn-Schmiedeberg Arch Pharmacol 355: 365-375.
18. Dubocovich ML, Cardinali DP, Guardoiola-Lemaitre B, Hagan RM, Krause DN, Sugden D, Yocca FD Vanhoutte PM. 1998. Melalonin receptors. In: Girdlestone E, editor. The IUPHAR compendium of receptor characterisation and classification. London: IU PHAR Media. p 188-193.
19. Ebisawa T, Karne S, Lerner MR, Reppert SM. 1994. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 91:6133-6137.
20. Edson K, Weisshaar B, Matus A. 1993. Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells. Development 117:689-700.
21. Eison AS. Mullins UL. 1993. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci 53:393-398.
22. Forscher P, Smith SJ. 1988. Actions of cytochalasins on the organization of actin filaments and microtubules in a neuronal growth cone. J Cell Biol 107:1505-1516.
23. Fukuda M, Gotoh Y, Tachibana T, Dell K, Hattori S., Yoneda Y, Nishida E. 1995. Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene 11:239-244.
24. 1 phase of nontransformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci USA 89:8626-8630.
25. Gilmore T, Martin GS. 1983. Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine. Nature 306:487-490.
26. Hashimoto K, Guroff G, Katagiri Y. 2000. Delayed and sustained activation of p42/p44 mitogen-activated protein kinase induced by proteasome inhibitors through p21(ras) in PC12 cells. J Neurochem 74:92-98.
27. Hazlerigg DG, Gonzalez-Brito A, Lawson W, Hastings MH, Morgan PJ. 1993. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from the ovine pituitary. Endocrinology 132:285-292.
28. Hei YJ, MacDonnell KL. McNeill JH, Diamond J. 1991. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol Pharmacol 39:233-238.
29. Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T. 1981. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci USA 78:4354-4357.
30. Jones MP, Melan MA, Witt-Enderby PA. 2000. Melatonin decreases cell proliferation and transformation in a receptor-dependent manner. Cancer Lett 151:133-143.
31. Krause DN, Barrios VE, Duckles SP. 1995. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 276: 207-213.
32. ÷÷5-733.
33. LeClerc N, Kosik KS, Cowan N, Pienkowski TP, Baas PW. 1993. Process formation in Sf9 cells induced by the expression of a microtubule-associated protein 2C-like construct. Proc Natl Acad Sci USA 90:6223-6227.
34. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. 1958. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 80:2587.
35. Levi-Montalcini R. 1987. The nerve growth factor 35 years later. Science 237:1154-1162.
36. Lieberman HR. 1985. Behavior, sleep and melatonin. In: Wurtman RJ, Waldhauser F, editors. Melatonin in humans. Cambridge: Center for Brain Sciences and Metabolism Charitable Trust. p 209-218.
37. Mandai K, Nakanishi H, Satoh A, Takahashi K, Satoh K, Nishioka H, Mizoguchi A, Takai Y. 1999. Ponsin/SH3P12 an 1-afadin-and vinculin binding protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 144:1001-1017.
38. Mazzucchelli C, Pannacci M, Nonno R, Lucini V, Fraschini F, Stankov BM. 1996. The melatonin receptor in human brain: cloning experiments and distribution studies. Mol Brain Res 39:117-126.
39. McArthur A., Hunt AE, Gillette MU. 1997. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627-634.
40. McNulty S, Morgan P, Thompson M, Davidson G, Lawson W, Hastings MH. 1994. Phospholipases and melatonin signal transduction in the ovine pars tuberalis. Mol Cell Endocrinol 99:73-79.
41. Melan MA, Sluder G. 1992. Redistribution and differential extraction of soluble proteins in permeabilized cultured cells: implications for immunofluorescence microscopy. J Cell Sci 101:731-743.
42. Melendez J, Maldonado V, Ortega A. 1996. Effect of melatonin on β-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res 21:653-658.
43. Molis TM, Spriggs LL, Hill SM. 1996. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 8:1681-1690.
44. Morgan PJ, Barrett P, Howell HE, Helliwell R. 1994. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 24:101-146.
45. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W, Zeller R. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cells. Exp Cell Res 236:248-258.
46. Murayama T, Kawashima M, Takahashi T, Yasuoka T, Kuwayama T, Tanaka, K. 1997. Direct action of melatonin on hen ovarian granulosa cells to lower responsiveness to luteinizing hormone. Proc Soc Exp Biol Med 215:386-392.
47. Nathan BP, Chang KC, Bellosta S, Brisch E. Ge N, Mahley RW, Pitas RE. 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799.
48. Niles LP, Hashimi F. 1990. Picomolar affinity binding and inhibition of adenylate cyclase activity by melatonin in Syrian hamster hypothalamus. Cell Mol Neurobiol 10:553-557.
49. Niles LP, Wang J, Shen L, Lobb DK, Younglai EV. 1999. Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol 156:107-110.
50. Osborn M, Weber K. 1982. Immunofluorescence and immunocytochemical procedures with affinity purified antibodies. Methods Cell Biol 24:97-132.
51. Patterson PH. 1992a. Process outgrowth and the specificity of connections. In: Hall ZW, editor. Molecular neurobiology. Sunderland, MA: Sinauer and Associates, p 388-427
52. Patterson PH. 1992b. Neuron-target interactions. In: Hall ZW, editor. Molecular neurobiology. Sunderland, MA: Sinauer and Associates, p 428-459
53. Petit, L, Lacroix I, de Coppet P, Strosberg AD, Jockers R. 1999. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′5″-monophosphate pathway. Biochem Pharmacol 58: 633-639.
54. Poffenharger M, Fuller GM. 1976. Is melatonin a microlubule inhibitor? Exp Cell Res 103:135-141.
55. Popova JS, Dubocovich ML. 1994. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J Neurochem 63:130-138.
56. Reppert SM, Weaver DR, Ebisawa. T. 1994. Cloning and characterization of a mammalian melatonin receptor that mediated reproductive and circadian responses. Neuron 13:1177-1185.
57. 1b melatonin receptor. Proc Natl Acad Sci USA 92:8734-8738.
58. Seamon K, Daly JW. 1981. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256:9799-9801.
59. Seeds NW, Gilman AG, Amano T, Nirenberg MW. 1970. Regulation of axon formation by clonal lines of a neural tumor. Proc Natl Acad Sci USA 66:160-167.
60. Sharp DJ, Kuryama R, Baas PW. 1996. Expression of a kinesin-related motor protein induces Sf9 cells to form dendrite-like processes with non-uniform microtubule polarity orientation. J Neurosci 16:4370-4375.
61. Sluder G. 1991. The practical use of colchicine and colcemid to reversibly block microtubule assembly in living cells. In: Adolph K, editor. Advanced techniques in chromosome research. New York: Marcel Dekker. p 427-447.
62. Song Y, Chan CWY, Brown GM, Pang SF, Silverman M. 1997. Studies of the renal action of melatonin: evidence that the effects are mediated by 37kDa receptors of the Mel1a subtype localixed primarily to the basolaleral membrane of the proximal tubule. FASEB J 11:93-100.
63. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. 1991. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 266:23856-23862.
64. Vale RD, Banker G, Hall ZW. 1992. The neuronal cytoskeleton. In Hall ZW, editor. Molecular neurobiology. Sunderland, MA: Sinauer and Associates, p 247-280.
65. Vaughan GC. 1984. Melatonin in humans. In: Reither RJ, editor. Pineal research reviews. II. New York: Wiley-Liss. p 151-201.
66. Viswanathan M, Laitinen JT, Saavedra JM. 1990. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA 87:6200-6203.
67. 1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol Pharmacol 50:166-174.
68. Witt-Enderby PA, Chu GH, Gillen ML, Li PK. 1997. The development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors. J Med Chem 40:4195-4198.
69. Yie S-M, Niles LP, Younglai EV. 1995. Melatonin receptors on human granulosa cell membranes. J Clin Endocrinol Metab 80:1747-1749.
70. Zmuda JF, Rivas RJ. 1998. The Golgi apparatus and the centrosome are localized to the sites of newly emerging axons in cerebellar granule neurons in vitro. Cell Motil Cytoskeleton 41:18-38.